Literature DB >> 30066914

Protective role of ABCG2 against oxidative stress in colorectal cancer and its potential underlying mechanism.

Shuang Nie1, Yaqing Huang2, Mengyue Shi1, Xuetian Qian1, Hongzhen Li1, Chunyan Peng1, Bo Kong1, Xiaoping Zou1, Shanshan Shen1.   

Abstract

Colorectal cancer (CRC), one of the most common cancer types worldwide, is associated with a high mortality rate, and oxidative stress and inflammation play a vital role in this malignancy. A previous study by our group indicated that ATP binding cassette subfamily G member 2 (ABCG2) was capable of protecting cells from reactive oxygen species (ROS)‑mediated cell damage and death. In the present study, the role of ABCG2 in CRC was investigated by using clinical samples and cell lines. The levels of oxidative stress markers and inflammatory factors were increased, while the levels of antioxidants were decreased in CRC tissues or the serum of patients. Notably, high expression of ABCG2 in CRC tissues which may be the feedback of over-oxidative reaction, was associated with a poor prognosis. Further in vitro study indicated that the downregulation of ABCG2 induced ROS generation and inflammatory reactions, and inhibited the production of antioxidants. The nuclear factor (NF)-κB signaling pathway was activated under oxidative stress induced by ABCG2 knockdown. In conclusion, the present results indicated that ABCG2 may relieve oxidative stress and inflammatory response by inhibiting the NF-κB signaling pathway in cell models, and may thus play a potential protective role in CRC. This information may provide novel theoretical mechanisms and future targets for CRC therapy.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30066914     DOI: 10.3892/or.2018.6594

Source DB:  PubMed          Journal:  Oncol Rep        ISSN: 1021-335X            Impact factor:   3.906


  9 in total

1.  Overexpression of ABCB1 and ABCG2 contributes to reduced efficacy of the PI3K/mTOR inhibitor samotolisib (LY3023414) in cancer cell lines.

Authors:  Chung-Pu Wu; Cheng-Yu Hung; Sabrina Lusvarghi; Yang-Hui Huang; Pin-Jung Tseng; Tai-Ho Hung; Jau-Song Yu; Suresh V Ambudkar
Journal:  Biochem Pharmacol       Date:  2020-07-04       Impact factor: 5.858

2.  Friend or foe: ABCG2, ABCC1 and ABCB1 expression in triple-negative breast cancer.

Authors:  Milica Nedeljković; Nasta Tanić; Mirjana Prvanović; Zorka Milovanović; Nikola Tanić
Journal:  Breast Cancer       Date:  2021-01-08       Impact factor: 4.239

3.  Network Pharmacology-Based Study on the Mechanism of Gegen Qinlian Decoction against Colorectal Cancer.

Authors:  Qiaowei Fan; Lin Guo; Jingming Guan; Jing Chen; Yujing Fan; Zhendong Chen; Hulun Li
Journal:  Evid Based Complement Alternat Med       Date:  2020-11-26       Impact factor: 2.629

4.  ALDH1A3 Accelerates Pancreatic Cancer Metastasis by Promoting Glucose Metabolism.

Authors:  Shuang Nie; Xuetian Qian; Mengyue Shi; Hongzhen Li; Chunyan Peng; Xiwei Ding; Shu Zhang; Bin Zhang; Guifang Xu; Ying Lv; Lei Wang; Helmut Friess; Bo Kong; Xiaoping Zou; Shanshan Shen
Journal:  Front Oncol       Date:  2020-06-16       Impact factor: 6.244

5.  Anti-Colorectal Cancer Mechanisms of Formononetin Identified by Network Pharmacological Approach.

Authors:  Lei Zhang; Yizhen Gong; Shuai Wang; Feng Gao
Journal:  Med Sci Monit       Date:  2019-10-14

6.  A network-based predictive gene expression signature for recurrence risks in stage II colorectal cancer.

Authors:  Wen-Jing Yang; Hai-Bo Wang; Wen-Da Wang; Peng-Yu Bai; Hong-Xia Lu; Chang-He Sun; Zi-Shen Liu; Ding-Kun Guan; Guo-Wang Yang; Gan-Lin Zhang
Journal:  Cancer Med       Date:  2019-11-14       Impact factor: 4.452

7.  sATP‑binding cassette subfamily G member 2 enhances the multidrug resistance properties of human nasal natural killer/T cell lymphoma side population cells.

Authors:  Shaoxuan Wu; Xudong Zhang; Meng Dong; Zhenzhen Yang; Mingzhi Zhang; Qingjiang Chen
Journal:  Oncol Rep       Date:  2020-08-10       Impact factor: 3.906

8.  The Novel Benzamide Derivative, VKNG-2, Restores the Efficacy of Chemotherapeutic Drugs in Colon Cancer Cell Lines by Inhibiting the ABCG2 Transporter.

Authors:  Silpa Narayanan; Nehaben A Gujarati; Jing-Quan Wang; Zhuo-Xun Wu; Jagadish Koya; Qingbin Cui; Vijaya L Korlipara; Charles R Ashby; Zhe-Sheng Chen
Journal:  Int J Mol Sci       Date:  2021-02-28       Impact factor: 5.923

9.  Machine Learning-Based Identification of Colon Cancer Candidate Diagnostics Genes.

Authors:  Saraswati Koppad; Annappa Basava; Katrina Nash; Georgios V Gkoutos; Animesh Acharjee
Journal:  Biology (Basel)       Date:  2022-02-25
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.